What Researchers Did
Researchers conducted a review of scientific studies published over the last decade to evaluate the quantity and quality of evidence for new adjunctive treatments and diagnostic methods for medication-related osteonecrosis of the jaw (MRONJ).
What They Found
The review identified numerous adjunctive treatments proposed in the last decade for MRONJ, including autologous platelet concentrates, hyperbaric oxygen, fluorescence-guided bone surgery, specific medical drugs, and laser therapy. These complementary treatments aim to reduce pain, manage bacterial infection, and improve wound healing, though their clinical effectiveness is described as more or less well documented.
What This Means for Canadian Patients
Canadian patients with medication-related osteonecrosis of the jaw may benefit from an increasingly conservative approach to treatment, with various adjunctive therapies being explored to manage symptoms and improve healing. These evolving options could lead to more personalized and effective care for this challenging condition.
Canadian Relevance
This study has no direct Canadian connection or specific data related to Canadian patients or healthcare systems.
Study Limitations
A limitation of this review is that the clinical effectiveness of many proposed adjunctive treatments for MRONJ is described as "more or less well documented," suggesting variability in the quality and quantity of available evidence.